External broker reports(aggregated public sources), Axis Direct

Axis Direct

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>Capital Infusion by Promoter : ACL (Ambuja Cements Limited) in its meeting held on 16th Sept, 2022 has decided to bring capital through equity infusion by issuing warrants (477.48 Mn) of Rs 2 each at a price of Rs 418.87/share totaling Rs 20000 Cr to Harmonia Trade &amp; Investment, a promoter group entity.</li><li>This will entail an equity dilution of 24.05%. With the converion of warrants into equity the promoters equity stake in the company will rise to 70.36% from the current 63.23% thereby increasing promoters stake in the company by 7.13%.</li><li>The warrants will be converted within 18 months from the date of the issue in one or more tranches.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Capital Infusion by Promoter : ACL (Ambuja Cements Limited) in its meeting held on 16th Sept, 2022 has decided to bring capital through equity infusion by issuing warrants (477.48 Mn) of Rs 2 each at a price of Rs 418.87/share totaling Rs 20000 Cr to Harmonia Trade &amp; Investment, a promoter group entity.This will entail an equity dilution of 24.05%. With the converion of warrants into equity the promoters equity stake in the company will rise to 70.36% from the current 63.23% thereby increasing promoters stake in the company by 7.13%.The warrants will be converted within 18 months from the date of the issue in one or more tranches.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Ambuja Cements Limited - Capital Infusion, A Catalyst For Future Growth.